Life Sciences: EU
Belgium
6 years ranked
Provided by Bird & Bird
As co-head of our International Life Sciences & Healthcare group and head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels, Marc provides cutting edge strategic and regulatory advice to our life sciences clients and represent them in litigation.
Marc offers both contentious and non-contentious strategic advice to Belgian and international pharma, biotech and medical devices companies, public bodies and national and European industry associations facing complex regulatory frameworks.
Marc's areas of expertise cover issues relating to life-cycle management, clinical trials and data, data exclusivity, marketing, price and reimbursement authorisations, and e-health together with data protection, distribution and advertising issues. Marc provides advice to biotech companies on issues regarding Advanced Therapy Medicinal Products as well as the legal and bioethical issues relating to research and use of human cells and tissues. He regularly represents clients before the nationals jurisdictions as well as before the European Court.
Marc's public and administrative law expertise covers the full range of sub practices in public procurement and related litigation, environmental law, REACH, RoHS, WEES and other Belgian and EU compliance issues.
Marc holds a law degree from the Vrije Universiteit Brussel (VUB), where he worked for four years as a research assistant, and a degree in public and administrative law from the University of Brussels. Before joining Bird & Bird, Marc was an expert adviser to the Vice-Prime Minister of Belgium for 3 years.
Marc speaks and publishes on life sciences regulatory topics and teaches an introduction to Biotech Law at the VUB. He is also on the board of the Belgian Biotech organisation BIO.BE.
Provided by Chambers
Marc Martens has prodigious expertise representing major generic pharmaceutical clients before EU courts, acting on disputes relating to market access and exclusivity. He is also highly sought after for his experience in transparency obligation mandates and reviewing clinical trial agreements.
Marc Martens has prodigious expertise representing major generic pharmaceutical clients before EU courts, acting on disputes relating to market access and exclusivity. He is also highly sought after for his experience in transparency obligation mandates and reviewing clinical trial agreements.
Chambers is the leading data and intelligence partner for the legal sector.